Report Content
Chapter 1 Methodology & Scope
1.1 Industry coverage
1.2 Market scope & definition
1.3 Base estimates & calculations
1.3.1 Data collection
1.4 Forecast parameters
1.5 COVID-19 impact analysis at global level
1.6 Data validation
1.7 Data Sources
1.7.1 Primary
1.7.2 Secondary
1.7.2.1 Paid sources
1.7.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Cardiac prosthetic devices industry 360º synopsis, 2018 – 2032
2.2 Business trends
2.3 Regional trends
2.4 Product trends
2.5 End-use trends
Chapter 3 Cardiac Prosthetic Devices Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increase in prevalence of cardiovascular diseases across the globe
3.2.1.2 Technological advancements in cardiac prosthetic devices
3.2.1.3 Increasing preferences for minimally invasive procedures among ageing population
3.2.1.4 Rising awareness and diagnosis for cardiac ailments
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of the devices
3.2.2.2 Dearth of skilled healthcare professionals
3.3 Growth potential analysis
3.3.1 By product
3.3.2 By end-use
3.4 COVID- 19 impact analysis
3.5 Regulatory landscape
3.6 Reimbursement scenario
3.7 Technology landscape
3.8 Future market trends
3.9 Porter's analysis
3.10 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Global company market share analysis, 2022
4.4 Vendor matrix analysis
4.5 Competitive positioning matrix
4.6 Strategy dashboard, 2022
Chapter 5 Cardiac Prosthetic Devices Market Size and Forecast, By Product (USD Million)
5.1 Key trends, by product
5.2 Heart Valves
5.2.1 Mechanical Heart Valve
5.2.2 Tissue Heart Valve
5.2.3 Transcatheter Heart Valve
5.3 Pacemaker
5.3.1 Implantable Pacemaker
5.3.2 External pacemakers
Chapter 6 Cardiac Prosthetic Devices Market Size and Forecast, By End-use (USD Million)
6.1 Key trends, by end-use
6.2 Hospitals
6.3 Ambulatory Surgical Centers
6.4 Others
Chapter 7 Cardiac Prosthetic Devices Market Size and Forecast, By Region (USD Million)
7.1 Key trends, by region
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 France
7.3.4 Spain
7.3.5 Italy
7.3.6 Poland
7.4 Asia Pacific
7.4.1 Japan
7.4.2 China
7.4.3 India
7.4.4 Australia
7.4.5 South Korea
7.4.6 Indonesia
7.5 Latin America
7.5.1 Brazil
7.5.2 Mexico
7.5.3 Argentina
7.6 MEA
7.6.1 South Africa
7.6.2 Saudi Arabia
7.6.3 UAE
Chapter 8 Company Profiles
8.1 Abbott Laboratories
8.2 Abiomed, Inc.
8.3 AtriCure, Inc.
8.4 Biotronik
8.5 Boston Scientific Corporation
8.6 CryoLife, Inc.
8.7 Edwards Lifesciences Corporation
8.8 Labcor Laboratrios
8.9 Lepu Medical Technology Co,. Ltd.
8.10 Lifetech Scientific
8.11 LivaNova
8.12 Medtronic plc.
8.13 Meril Life Sciences Pvt. Ltd.
8.14 MicroPort Scientific
8.15 Siemens Healthcare GmbH
